| Aha | Eptifibatide |
| Nọmba CAS | 188627-80-7 |
| Usoro ihe omimi | C35H49N11O9S2 |
| Ibu arọ molekụla | 831.96 |
| Nọmba EINECS | 641-366-7 |
| Njupụta | 1.60±0.1 g/cm3 (buru amụma) |
| Ọnọdụ nchekwa | E mechiri ya na nkụ, chekwaa ya na friza, n'okpuru -15 Celsius |
Eptifibatideacetatesalt;Eptifibatide,MPA-HAR-Gly-Asp-Trp-Pro-Cys-NH2,MPAHARGDWPC-NH2,>99%;MAP-LYS-GLY-ASP-TRP-PRO-CYS-NH2;INTEGRELIN;Eptifibatide(Amin); nomethyl) -N2- (3-mercapto-1-oxopropyl-L-lysylglycyl-La-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide;MPA-HAR-GLY-ASP-TRP-PRO-CYS-NH2(DISULFIDEBRIDGE,MPA1-CYS6).
Etifibatide (integrilin) bụ akwụkwọ akụkọ polypeptide platelet glycoprotein IIb/IIIa antagonist nke na-egbochi nchịkọta platelet na thrombosis site na igbochi ụzọ ikpeazụ nke nchịkọta platelet. E jiri ya tụnyere monoclonal antibody abciximab, eptifibatide nwere njikọ siri ike, ntụzịaka na nke akọwapụtara na GPIIb/IIIa n'ihi ịdị adị nke otu nnọchi amino acid na-agbanwe agbanwe-lysine iji dochie arginine. Ya mere, ọ kwesịrị inwe mmetụta ọgwụgwọ dị mma na ntinye aka nke nnukwu ọrịa obi. Platelet glycoprotein IIb/IIIa antagonist antagonist emeputala nke ukwuu, ma ugbu a enwere ụdị nkwadebe atọ enwere ike iji na ụlọ ọgwụ na mba ụwa, abciximab, eptifibatide na tirofiban. ). Enweghi ahụmịhe dị nta n'iji platelet glycoprotein GPIIb/IIa ndị na-emegide ndị na-anabata ihe na China, yana ọgwụ ndị dịnụ nwekwara oke oke. Naanị otu ọgwụ, tirofiban hydrochloride, dị n'ahịa. Ya mere, e mepụtara platelet glycoprotein IIb ọhụrụ. /IIIa ndị na-emegide ndị na-anabata ya dị mkpa. Eptifibatide ụlọ bụ ngwaahịa nṅomi nke Chengdu Sino Biological Products Co., Ltd mepụtara.
Nhazi nke ọgwụ nchịkọta Antiplatelet
Enwere ike kewaa ọgwụ mgbochi antiplatelet ụzọ atọ: 1. Cyclooxygenase-1 (COX-1) inhibitors, dị ka aspirin. 2. Na-egbochi nchịkọta platelet na-akpata site na adenosine diphosphate (ADP), dị ka clopidogrel, prasugrel, cangrelor, ticagrelor, wdg. Akụkụ kemịkalụ arụpụtara ọhụrụ yana mpụta dị irè sitere na ọgwụ ọdịnala ndị China.